Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as an adjuvant to TAP block in gynecologic laparoscopic surgery
ChiCTR2300067543Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Jinan University
- Start
- Jan 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and ropivacaine in postoperative pain and postoperative recovery (4 arms), sponsored by First Affiliated Hospital of Jinan University. Primary endpoints: Pain scores and Quality of recovery. Started Jan 2023; status: recruiting.
02
Drugs
dexmedetomidineropivacaine
03
Conditions
postoperative painpostoperative recovery
Beyond the preview
Go deeper on ChiCTR2300067543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300067543.